13F filing recap · Q1 2024

What did Patient Capital Management buy in Q1 2024?

Reported stock-position changes between this filing and the previous one.

Stock value

$2.05B

Positions

Estimated turnover

16.3%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

NVDANvidia Corp$54.76Mreported value+60.6K shares BIIBBiogen Inc.$46.98Mreported value+217.9K shares FBTCFidelity® Wise Origin® Bitcoin Fund$6.98Mreported value+112.4K shares

Increased positions

DALDelta Air Lines, Inc.$91.74Mreported value+3.1K shares+0.2%GOOGLAlphabet Inc.$90.79Mreported value+949 shares+0.2%ETEnergy Transfer LP$89.32Mreported value+67.3K shares+1.2%PPLIIac Inc.$76.67Mreported value+70.4K shares

Reduced positions

AMZNAmazon.com Inc$116.16Mreported value-78.2K shares-10.8%CCitigroup Inc$112.38Mreported value-112.3K shares-5.9%EXPEExpedia Group, Inc.$100.50Mreported value-205.9K shares-22.0%OMFOnemain Holdings, Inc.$95.22Mreported value-285.2K shares

Exited positions

CLFCleveland-Cliffs Inc.$20.97Mprior reported value-1.03M shares-100.0%KRTXKaruna Therapeutics Inc$3.68Mprior reported value-11.6K shares-100.0%SPYSPDR S&P 500 ETF Trust$994.0Kprior reported value-2.1K shares-100.0%